These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 817527)

  • 1. [Parameters for the measurement of long-term effects of an orally administered drug in organic and functional circulatory disorders. Preliminary communication].
    Schuster CJ; von Ungern-Sternberg AF
    ZFA (Stuttgart); 1976 Jan; 52(2):105-10. PubMed ID: 817527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
    Brüning G
    Med Welt; 1975 Sep; 26(38):1737-41. PubMed ID: 810634
    [No Abstract]   [Full Text] [Related]  

  • 3. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
    Heidrich H
    Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1219-24. PubMed ID: 3926447
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
    Masini G
    Minerva Cardioangiol; 1975 Feb; 23(2):120-5. PubMed ID: 1095956
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of chronic arterial occlusive disease. Studies with an orally administered drug under ambulatory conditions].
    Wampola H
    Fortschr Med; 1977 May; 95(18):1240,1242-5. PubMed ID: 405291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
    De Gregorio G; Restivo S
    Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
    [No Abstract]   [Full Text] [Related]  

  • 8. [Conservative treatment of peripheral arterial occlusive diseases].
    Hoffmann J
    Fortschr Med; 1978 Sep; 96(34):1735-8. PubMed ID: 101431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of organic psychosyndromes of cerebrovascular origin with a vasoactive drug combination].
    Lesch OM; Musalek M; Dietzel M; Grünberger J; Saletu B; Schjerve M; Walter H; Werner U; Zeiler K
    Wien Med Wochenschr; 1985 Sep; 135(18):459-65. PubMed ID: 3933188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Capilloroscopy of nail folds in Raynaud's syndrome during Hypacom treatment].
    Bendkowski W; Bogdanowski T
    Pol Tyg Lek; 1978 Oct; 33(41):1619-20. PubMed ID: 704471
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and therapy of Raynaud's phenomenon (author's transl)].
    Goebel KM; Neitzert A
    Ther Umsch; 1975 Jun; 32(6):350-6. PubMed ID: 806127
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical use of thymoxamine in peripheral arterial pathology].
    Ghiglino GC; Viacava A; Gori A; Misuri A; Lucertini G; Pelagatti M
    Clin Ter; 1983 Apr; 105(2):103-7. PubMed ID: 6222862
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1981 Feb; 125(6):228-34. PubMed ID: 7207673
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous infusions in the treatment of arterial occlusive diseases from the surgical point of view].
    Hugeneck J
    Wien Med Wochenschr; 1976 Sep; 126(38):542-4. PubMed ID: 788353
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term treatment of arterial occlusive diseases using vasodilator agents].
    Bartusch M; Mörl H; Ridha G; Preubb EG
    Z Gesamte Inn Med; 1973 May; 28(9):Suppl 9:137-9. PubMed ID: 4199964
    [No Abstract]   [Full Text] [Related]  

  • 17. [Reaction of the conjunctival and retinal vessels to the administration of vasodilators to patients with vascular disorders of the fundus oculi].
    Davydova NG; Bunin AIa; Nikol'skaia VV; Lysenko VS; Iakovleva AA
    Vestn Oftalmol; 1985; 101(3):38-40. PubMed ID: 4035869
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vasospasm of the pial arteries in the rabbit].
    Reuse S
    Boll Soc Ital Cardiol; 1977; 22(7):1092-3. PubMed ID: 109104
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical treatment of peripheral arterial occlusive diseases].
    Schulte B
    Fortschr Med; 1976 Sep; 94(27):1500-4. PubMed ID: 823087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dihydroergocristine in the treatment of Raynaud's disease].
    Castelli PM; Sironi G
    Minerva Cardioangiol; 1977 Sep; 25(9):757-63. PubMed ID: 413069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.